Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00465855 · ClinicalTrials.gov registry record · Phase 4
One vs. Three Hyperbaric Oxygen Treatments for Acute Carbon Monoxide Poisoning
A Phase 4 study, sponsored by Intermountain Health Care.
- Completed
- Registry status
- Phase 4
- Development phase
- 75
- Enrollment target
NCT00465855: Completed Phase 4 study, sponsored by Intermountain Health Care.
NCT00465855 is a Phase 4 study that has completed, run by Intermountain Health Care. The registered enrollment target is 75 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00465855, a Phase 4 study, has completed, sponsored by Intermountain Health Care.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 75 participants
- Enrollment target
Study Summary
This randomized trial will investigate important clinical outcomes of patients with acute carbon monoxide poisoning randomized to receive either one or three hyperbaric oxygen treatments.
Primary Outcome
Presence of cognitive sequelae at 6-week follow-up
Interventions
- COMBINATION_PRODUCT Hyperbaric Oxygen (HBO2) - 3 sessions
- COMBINATION_PRODUCT Hyperbaric Oxygen (HBO2) - 1 session
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2007-06-03 |
| Est. Completion | 2017-01-28 |
| Phase | Phase 4 |
What the finished NCT00465855 record still lists
NCT00465855 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 2 interventions - of which Hyperbaric Oxygen (HBO2) - 3 sessions is the first listed.
NCT00465855 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00465855 about?
NCT00465855 is a clinical study titled "One vs. Three Hyperbaric Oxygen Treatments for Acute Carbon Monoxide Poisoning". This randomized trial will investigate important clinical outcomes of patients with acute carbon monoxide poisoning randomized to receive either one or three hyperbaric oxygen treatments.
What is the current status of trial NCT00465855?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 75 participants. The study started on 2007-06-03. Estimated completion is 2017-01-28.
What interventions are being tested in trial NCT00465855?
The interventions under investigation include: Hyperbaric Oxygen (HBO2) - 3 sessions (COMBINATION_PRODUCT), Hyperbaric Oxygen (HBO2) - 1 session (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT00465855?
This trial is sponsored by Intermountain Health Care, which has 85 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00465855's enrollment target sits among peer trials
75 1002nd of 2000 higher than 974 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI